LENZ Therapeutics Inc Sustainability Reports

LENZ Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision. Its primary product is an FDA-approved eye drop solution for the treatment of presbyopia in adults.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

FIGI: BBG00XDH4P05

No reports are currently available in our catalogue.